Advanced search
Publication Cover
Open Access Emergency Medicine Volume 12, 2020 - Issue
Submit an article Journal homepage
122
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Serum Cleaved Tau Protein and Clinical Outcome in Patients with Minor Head Trauma

Arash Forouzan1 Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranORCID Iconhttps://orcid.org/0000-0003-0754-9779View further author information
ORCID Icon,
Hassan Motamed1 Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranORCID Iconhttps://orcid.org/0000-0001-9062-085XView further author information
ORCID Icon,
Ali Delirrooyfard1 Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence[email protected]
View further author information
&
Sara Zallaghi2 Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranView further author information
Pages 7-12 | Published online: 20 Jan 2020

References

  • Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21(5):375–378. doi:10.1097/00001199-200609000-00001
  • Shively SB, Perl DP. Traumatic brain injury, shell shock, and posttraumatic stress disorder in the military–past, present, and future. J Head Trauma Rehabil. 2012;27(3):234–239. doi:10.1097/HTR.0b013e318250e9dd
  • Kelly JC, Amerson EH, Barth JT. Mild traumatic brain injury: lessons learned from clinical, sports, and combat concussions. Rehabil Res Pract. 2012;2012:371970. doi:10.1155/2012/371970
  • Ma M, Lindsell CJ, Rosenberry CM, Shaw GJ, Zemlan FP. Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury. Am J Emerg Med. 2008;26(7):763–768. doi:10.1016/j.ajem.2007.10.029
  • Bulut M, Koksal O, Dogan S, et al. Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary results. Adv Ther. 2006;23(1):12–22. doi:10.1007/BF02850342
  • Chiu WT, Huang SJ, Tsai SH, et al. The impact of time, legislation, and geography on the epidemiology of traumatic brain injury. J Clini Neurosci. 2007;14(10):930–935. doi:10.1016/j.jocn.2006.08.004
  • Johnson VE, Stewart W, Smith DH. Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer’s disease? Nature Rev Neurosci. 2010;11(5):361–370. doi:10.1038/nrn2808
  • Li LM, Menon DK, Janowitz T. Cross-sectional analysis of data from the US clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke. PLoS ONE. 2014;9(1):e84336. doi:10.1371/journal.pone.0084336
  • Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. 2007;22(5):341–353.
  • Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj. 2006;20(7):759–765. doi:10.1080/02699050500488207
  • Sharma R, Laskowitz DT. Biomarkers in traumatic brain injury. Curr Neurol Neurosci Rep. 2012;12(5):560–569. doi:10.1007/s11910-012-0301-8
  • Bettermann K, Slocomb JE. Clinical relevance of biomarkers for traumatic brain injury. Biomark Traum Brain Inj. 2012;1–18.
  • Sivanandam TM, Thakur MK. Traumatic brain injury: a risk factor for Alzheimer’s disease. Neurosci Biobehav Rev. 2012;36(5):1376–1381. doi:10.1016/j.neubiorev.2012.02.013
  • Blennow K, Hampel H. CSF markers for incipient Alzheimer’s disease. Lancet Neurol. 2003;2(10):605–613. doi:10.1016/S1474-4422(03)00530-1
  • Selkoe DJ, Schenk D. Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol. 2003;43:545–584. doi:10.1146/annurev.pharmtox.43.100901.140248
  • Rubenstein R, Chang B, Davies P, Wagner AK, Robertson CS, Wang KK. A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids. J Neurotrauma. 2015;32(5):342–352. doi:10.1089/neu.2014.3548
  • Jeter CB, Hergenroeder GW, Hylin MJ, Redell JB, Moore AN, Dash PK. Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion. J Neurotrauma. 2013;30(8):657–670. doi:10.1089/neu.2012.2439
  • Crowther RA, Goedert M. Abnormal tau-containing filaments in neurodegenerative diseases. J Struct Biol. 2000;130(2–3):271–279. doi:10.1006/jsbi.2000.4270
  • Caballero B, Wang Y, Diaz A, et al. Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell. 2018;17:1. doi:10.1111/acel.2018.17.issue-1
  • Begaz T, Kyriacou DN, Segal J, Bazarian JJ. Serum biochemical markers for post-concussion syndrome in patients with mild traumatic brain injury. J Neurotrauma. 2006;23(8):1201–1210. doi:10.1089/neu.2006.23.1201
  • Kavalci C, Pekdemir M, Durukan P, et al. The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. Am J Emerg Med. 2007;25(4):391–395. doi:10.1016/j.ajem.2006.10.008
  • Guzel A, Karasalihoglu S, Aylanc H, Temizoz O, Hicdonmez T. Validity of serum tau protein levels in pediatric patients with minor head trauma. Am J Emerg Med. 2010;28(4):399–403. doi:10.1016/j.ajem.2008.12.025
  • Olczak M, Niderla-Bielinska J, Kwiatkowska M, Samojlowicz D, Tarka S, Wierzba-Bobrowicz T. Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination. Forensic Sci Int. 2017;280:1–7. doi:10.1016/j.forsciint.2017.09.008

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.